id	sid	eid	entity	type
ijpds-3902	1	1	chandur & shabaraya	ORG
ijpds-3902	1	2	2	CARDINAL
ijpds-3902	1	3	2 | apr –	TIME
ijpds-3902	1	4	2023	CARDINAL
ijpds-3902	1	5	indian	NORP
ijpds-3902	1	6	j pharm drug	PRODUCT
ijpds-3902	1	7	82	CARDINAL
ijpds-3902	1	8	chandur1	ORG
ijpds-3902	1	9	1	CARDINAL
ijpds-3902	2	1	prof	PERSON
ijpds-3902	2	2	2	CARDINAL
ijpds-3902	2	3	department of pharmaceutics	ORG
ijpds-3902	2	4	srinivas college	ORG
ijpds-3902	3	1	viresh k chandur	PERSON
ijpds-3902	3	2	asso	ORG
ijpds-3902	4	1	prof.	ORG
ijpds-3902	5	1	department of pharmaceutics	ORG
ijpds-3902	5	2	srinivas college	ORG
ijpds-3902	6	1	9742565141	DATE
ijpds-3902	6	2	viresh.chandur2009@gmail.com	ORG
ijpds-3902	8	1	$107.2 million	MONEY
ijpds-3902	8	2	2020	DATE
ijpds-3902	8	3	$187.3 million	MONEY
ijpds-3902	8	4	2030	DATE
ijpds-3902	8	5	5.2%	PERCENT
ijpds-3902	8	6	2021	CARDINAL
ijpds-3902	8	7	2030	CARDINAL
ijpds-3902	10	1	1:1	CARDINAL
ijpds-3902	10	2	5.1	CARDINAL
ijpds-3902	10	3	15.2	CARDINAL
ijpds-3902	10	4	42.2	CARDINAL
ijpds-3902	10	5	96.5 to 98.8%	PERCENT
ijpds-3902	10	6	1.1042	CARDINAL
ijpds-3902	10	7	1.1062	CARDINAL
ijpds-3902	10	8	594.5	CARDINAL
ijpds-3902	11	1	lps3	PERSON
ijpds-3902	11	2	10ml	CARDINAL
ijpds-3902	11	3	1%	PERCENT
ijpds-3902	14	1	ecent	ORG
ijpds-3902	14	2	1	CARDINAL
ijpds-3902	15	1	lifestyle interventions"—to	ORG
ijpds-3902	15	2	the past ten years	DATE
ijpds-3902	16	1	one	CARDINAL
ijpds-3902	16	2	2	CARDINAL
ijpds-3902	19	1	35–40	CARDINAL
ijpds-3902	21	1	one	CARDINAL
ijpds-3902	23	1	3	CARDINAL
ijpds-3902	27	1	4	CARDINAL
ijpds-3902	29	1	5	CARDINAL
ijpds-3902	30	1	karnataka	NORP
ijpds-3902	30	2	the month of january 2018	DATE
ijpds-3902	30	3	mailto:viresh.chandur2009@gmail.com chandur & shabaraya	ORG
ijpds-3902	30	4	2	CARDINAL
ijpds-3902	31	1	2 | apr –	TIME
ijpds-3902	31	2	2023	CARDINAL
ijpds-3902	31	3	indian	NORP
ijpds-3902	31	4	j pharm drug	PRODUCT
ijpds-3902	31	5	83	CARDINAL
ijpds-3902	31	6	n-hexane	PRODUCT
ijpds-3902	31	7	merck chemicals	ORG
ijpds-3902	32	1	two	CARDINAL
ijpds-3902	33	1	2011	DATE
ijpds-3902	33	2	jain s et al.	ORG
ijpds-3902	33	3	2019	DATE
ijpds-3902	33	4	6	CARDINAL
ijpds-3902	34	1	1	CARDINAL
ijpds-3902	34	2	1	CARDINAL
ijpds-3902	34	3	lps2 lps3	PERSON
ijpds-3902	34	4	10mg / 5ml	QUANTITY
ijpds-3902	35	1	10mg / 5ml	QUANTITY
ijpds-3902	36	1	10mg / 5ml	QUANTITY
ijpds-3902	37	1	10mg / 5ml	QUANTITY
ijpds-3902	38	1	10 ml 10 ml 10 ml 10 ml glycerin	QUANTITY
ijpds-3902	38	2	10 ml 10 ml 10 ml 10 ml	QUANTITY
ijpds-3902	38	3	1%	PERCENT
ijpds-3902	38	4	5 ml 10 ml	QUANTITY
ijpds-3902	38	5	1%	PERCENT
ijpds-3902	38	6	5 ml 10 ml methyl paraben	QUANTITY
ijpds-3902	38	7	0.09	CARDINAL
ijpds-3902	38	8	0.01 0.01 0.01 0.01	MONEY
ijpds-3902	38	9	50 ml 50 ml 50 ml 50 ml	QUANTITY
ijpds-3902	40	1	four	CARDINAL
ijpds-3902	40	2	lps2	GPE
ijpds-3902	40	3	lps3	PERSON
ijpds-3902	40	4	5	CARDINAL
ijpds-3902	40	5	10 millilitres	QUANTITY
ijpds-3902	40	6	1%	PERCENT
ijpds-3902	42	1	four	CARDINAL
ijpds-3902	43	1	8	CARDINAL
ijpds-3902	44	1	1	CARDINAL
ijpds-3902	45	1	four	CARDINAL
ijpds-3902	45	2	lps2	GPE
ijpds-3902	45	3	lps3	PERSON
ijpds-3902	47	1	50.0 ml	QUANTITY
ijpds-3902	47	2	about 5 ml	QUANTITY
ijpds-3902	49	1	brookfield viscometer	ORG
ijpds-3902	50	1	100	CARDINAL
ijpds-3902	53	1	9	CARDINAL
ijpds-3902	54	1	5ml	CARDINAL
ijpds-3902	54	2	100 ml	QUANTITY
ijpds-3902	55	1	50	CARDINAL
ijpds-3902	55	2	0.1 n hcl	QUANTITY
ijpds-3902	55	3	30 min	DATE
ijpds-3902	57	1	1 ml	QUANTITY
ijpds-3902	57	2	10ml	CARDINAL
ijpds-3902	57	3	0.1 n hcl	QUANTITY
ijpds-3902	58	1	471	CARDINAL
ijpds-3902	59	1	10	CARDINAL
ijpds-3902	59	2	malvern	LAW
ijpds-3902	59	3	7.13	CARDINAL
ijpds-3902	60	1	11	CARDINAL
ijpds-3902	61	1	37 ± 0.5ºc	QUANTITY
ijpds-3902	61	2	50	CARDINAL
ijpds-3902	61	3	900 ml	QUANTITY
ijpds-3902	62	1	1.2	CARDINAL
ijpds-3902	63	1	10 mg	QUANTITY
ijpds-3902	64	1	5 ml	QUANTITY
ijpds-3902	64	2	0.45 μm	QUANTITY
ijpds-3902	64	3	471	CARDINAL
ijpds-3902	66	1	2	CARDINAL
ijpds-3902	66	2	6.8	CARDINAL
ijpds-3902	66	3	10	CARDINAL
ijpds-3902	67	1	12	CARDINAL
ijpds-3902	68	1	1mmol/l	DATE
ijpds-3902	68	2	31.54 mg	QUANTITY
ijpds-3902	68	3	95%	PERCENT
ijpds-3902	68	4	0.1 mol/l	QUANTITY
ijpds-3902	68	5	chandur & shabaraya	ORG
ijpds-3902	68	6	2	CARDINAL
ijpds-3902	69	1	2 | apr –	TIME
ijpds-3902	69	2	2023	CARDINAL
ijpds-3902	69	3	indian	NORP
ijpds-3902	69	4	j pharm drug	PRODUCT
ijpds-3902	69	5	84 ph 5.5	CARDINAL
ijpds-3902	69	6	60 ml	QUANTITY
ijpds-3902	69	7	up to	CARDINAL
ijpds-3902	69	8	50 ml	QUANTITY
ijpds-3902	70	1	1 mg	QUANTITY
ijpds-3902	70	2	2mg	QUANTITY
ijpds-3902	70	3	4mg	QUANTITY
ijpds-3902	70	4	8 mg	QUANTITY
ijpds-3902	70	5	up to	QUANTITY
ijpds-3902	70	6	4 ml	QUANTITY
ijpds-3902	71	1	1 ml	QUANTITY
ijpds-3902	71	2	1mmol	CARDINAL
ijpds-3902	71	3	3.953x10	CARDINAL
ijpds-3902	71	4	300c	CARDINAL
ijpds-3902	71	5	30 min	DATE
ijpds-3902	72	1	471	CARDINAL
ijpds-3902	74	1	0.2	CARDINAL
ijpds-3902	74	2	0.4	CARDINAL
ijpds-3902	74	3	0.6	CARDINAL
ijpds-3902	74	4	0.8	CARDINAL
ijpds-3902	74	5	1.0 ml	QUANTITY
ijpds-3902	74	6	1 mg/ml	QUANTITY
ijpds-3902	74	7	4 ml	QUANTITY
ijpds-3902	75	1	1 ml	QUANTITY
ijpds-3902	75	2	1nmom/l	DATE
ijpds-3902	76	1	0.500 ± 0.040	QUANTITY
ijpds-3902	77	1	1%	PERCENT
ijpds-3902	79	1	100	CARDINAL
ijpds-3902	80	1	13	CARDINAL
ijpds-3902	81	1	75±5%	PERCENT
ijpds-3902	81	2	6 months	DATE
ijpds-3902	82	1	each month	DATE
ijpds-3902	83	1	11	CARDINAL
ijpds-3902	84	1	2	CARDINAL
ijpds-3902	87	1	2	CARDINAL
ijpds-3902	87	2	450.5	CARDINAL
ijpds-3902	87	3	467.1	CARDINAL
ijpds-3902	87	4	21.7	CARDINAL
ijpds-3902	87	5	23.2	CARDINAL
ijpds-3902	87	6	0.515 to 0.591	CARDINAL
ijpds-3902	88	1	3	CARDINAL
ijpds-3902	88	2	3	CARDINAL
ijpds-3902	88	3	2	CARDINAL
ijpds-3902	88	4	100	CARDINAL
ijpds-3902	89	1	29.5	CARDINAL
ijpds-3902	89	2	1.1058 98.8	CARDINAL
ijpds-3902	89	3	lps2	ORG
ijpds-3902	89	4	4.5	CARDINAL
ijpds-3902	89	5	18.0	CARDINAL
ijpds-3902	89	6	97.8	CARDINAL
ijpds-3902	89	7	lps3	ORG
ijpds-3902	89	8	4.9	CARDINAL
ijpds-3902	89	9	5.1	CARDINAL
ijpds-3902	89	10	22.3 11.6	QUANTITY
ijpds-3902	89	11	97.2	CARDINAL
ijpds-3902	89	12	3	CARDINAL
ijpds-3902	90	1	464.8 21.7 0.515	QUANTITY
ijpds-3902	90	2	lps2	ORG
ijpds-3902	90	3	450.5	CARDINAL
ijpds-3902	90	4	0.578	CARDINAL
ijpds-3902	90	5	lps3	ORG
ijpds-3902	90	6	467.1	CARDINAL
ijpds-3902	90	7	0.521	CARDINAL
ijpds-3902	90	8	594.4 0.591	CARDINAL
ijpds-3902	90	9	3	CARDINAL
ijpds-3902	90	10	lps3 chandur & shabaraya	ORG
ijpds-3902	90	11	2	CARDINAL
ijpds-3902	90	12	2 | apr –	TIME
ijpds-3902	90	13	2023	CARDINAL
ijpds-3902	90	14	indian	NORP
ijpds-3902	90	15	j pharm drug	PRODUCT
ijpds-3902	90	16	85	CARDINAL
ijpds-3902	91	1	8 to 60 %	PERCENT
ijpds-3902	91	2	between 9 to 61 %	CARDINAL
ijpds-3902	93	1	fig 4	ORG
ijpds-3902	94	1	less than	PERCENT
ijpds-3902	94	2	14%	PERCENT
ijpds-3902	94	3	first 2 hours	TIME
ijpds-3902	94	4	more than 95%	PERCENT
ijpds-3902	94	5	10 hours	TIME
ijpds-3902	94	6	6.8	CARDINAL
ijpds-3902	94	7	lps2	GPE
ijpds-3902	94	8	10 ml	QUANTITY
ijpds-3902	94	9	1%	PERCENT
ijpds-3902	94	10	12 hours	TIME
ijpds-3902	94	11	up to 10	CARDINAL
ijpds-3902	94	12	5	CARDINAL
ijpds-3902	97	1	4	CARDINAL
ijpds-3902	97	2	lps2	GPE
ijpds-3902	97	3	lps2	GPE
ijpds-3902	97	4	25±2o	CARDINAL
ijpds-3902	97	5	40±2o	CARDINAL
ijpds-3902	97	6	6 months month	DATE
ijpds-3902	97	7	the end of 12	DATE
ijpds-3902	97	8	1 4.50	CARDINAL
ijpds-3902	97	9	42.23	CARDINAL
ijpds-3902	97	10	98.06	CARDINAL
ijpds-3902	97	11	4.60	CARDINAL
ijpds-3902	97	12	41.23	CARDINAL
ijpds-3902	98	1	98.01	CARDINAL
ijpds-3902	98	2	2 4.50	CARDINAL
ijpds-3902	98	3	42.20	CARDINAL
ijpds-3902	98	4	98.00	CARDINAL
ijpds-3902	98	5	4.65	CARDINAL
ijpds-3902	99	1	41.00	CARDINAL
ijpds-3902	100	1	98.00	CARDINAL
ijpds-3902	100	2	3 4.50	CARDINAL
ijpds-3902	100	3	42.23	CARDINAL
ijpds-3902	100	4	98.00	CARDINAL
ijpds-3902	100	5	4.60	CARDINAL
ijpds-3902	100	6	41.20	CARDINAL
ijpds-3902	101	1	98.00	CARDINAL
ijpds-3902	101	2	4 4.60	CARDINAL
ijpds-3902	101	3	42.40	CARDINAL
ijpds-3902	102	1	96.58	CARDINAL
ijpds-3902	102	2	4.60	CARDINAL
ijpds-3902	102	3	41.21	CARDINAL
ijpds-3902	103	1	96.40	CARDINAL
ijpds-3902	103	2	5 4.60	CARDINAL
ijpds-3902	103	3	42.31	CARDINAL
ijpds-3902	103	4	96.21	CARDINAL
ijpds-3902	103	5	4.65	CARDINAL
ijpds-3902	103	6	42.00	CARDINAL
ijpds-3902	104	1	96.11	CARDINAL
ijpds-3902	104	2	6 4.65	CARDINAL
ijpds-3902	104	3	42.24	CARDINAL
ijpds-3902	105	1	95.86	CARDINAL
ijpds-3902	105	2	4.60	CARDINAL
ijpds-3902	105	3	8 41.23	CARDINAL
ijpds-3902	106	1	95.12	CARDINAL
ijpds-3902	106	2	10 ml	QUANTITY
ijpds-3902	106	3	1%	PERCENT
ijpds-3902	109	1	12 hours	TIME
ijpds-3902	111	1	karnataka	GPE
ijpds-3902	111	2	srinivas college	PERSON
ijpds-3902	112	1	1	CARDINAL
ijpds-3902	113	1	s. estimation of	ORG
ijpds-3902	113	2	daily	DATE
ijpds-3902	113	3	korea	GPE
ijpds-3902	114	1	2020	DATE
ijpds-3902	114	2	1-11	CARDINAL
ijpds-3902	115	1	muhammad	PERSON
ijpds-3902	115	2	iahtisham ul-haq	PERSON
ijpds-3902	116	1	2020	DATE
ijpds-3902	116	2	9(706	CARDINAL
ijpds-3902	116	3	1-27	DATE
ijpds-3902	117	1	3	CARDINAL
ijpds-3902	117	2	muhammad	PERSON
ijpds-3902	117	3	abdul rk.	PERSON
ijpds-3902	118	1	world journal	ORG
ijpds-3902	118	2	2020	DATE
ijpds-3902	118	3	5(2	DATE
ijpds-3902	118	4	26	CARDINAL
ijpds-3902	118	5	0 100 %	PERCENT
ijpds-3902	119	1	io	LOC
ijpds-3902	120	1	0	CARDINAL
ijpds-3902	120	2	120	CARDINAL
ijpds-3902	120	3	10 15 %	PERCENT
ijpds-3902	120	4	lps3 lps4	PERSON
ijpds-3902	120	5	lps2 chandur & shabaraya	ORG
ijpds-3902	121	1	2	CARDINAL
ijpds-3902	121	2	2 | apr –	TIME
ijpds-3902	121	3	2023	CARDINAL
ijpds-3902	121	4	indian	NORP
ijpds-3902	121	5	j pharm drug	PRODUCT
ijpds-3902	121	6	86 4	DATE
ijpds-3902	122	1	fatima m. saeed k. analysis	PERSON
ijpds-3902	123	1	bio	PERSON
ijpds-3902	123	2	revi	PERSON
ijpds-3902	124	1	2020;2(2):23-32	CARDINAL
ijpds-3902	125	1	5	CARDINAL
ijpds-3902	125	2	ying h	PERSON
ijpds-3902	125	3	hong c	GPE
ijpds-3902	125	4	yuhao s	PERSON
ijpds-3902	126	1	nj	ORG
ijpds-3902	127	1	2021;20(43):1-10	CARDINAL
ijpds-3902	128	1	aghel n	PERSON
ijpds-3902	128	2	amirfakhrian	ORG
ijpds-3902	128	3	dezfoul	GPE
ijpds-3902	128	4	iran	GPE
ijpds-3902	128	5	2011	DATE
ijpds-3902	128	6	6(1	CARDINAL
ijpds-3902	128	7	9-15	DATE
ijpds-3902	129	1	7	CARDINAL
ijpds-3902	129	2	jain s	PERSON
ijpds-3902	129	3	srivastva s	ORG
ijpds-3902	129	4	soni shankar lal	PERSON
ijpds-3902	129	5	2019	DATE
ijpds-3902	129	6	-65-73 8	EVENT
ijpds-3902	130	1	ravi	ORG
ijpds-3902	131	1	j. pharmtech res	PERSON
ijpds-3902	131	2	2015	CARDINAL
ijpds-3902	131	3	5:(4)1-13	CARDINAL
ijpds-3902	132	1	9	CARDINAL
ijpds-3902	133	1	beny b	PERSON
ijpds-3902	133	2	prakash rao b.	PERSON
ijpds-3902	133	3	metformin hcl	PERSON
ijpds-3902	133	4	j. pharm	ORG
ijpds-3902	134	1	sci. & res	ORG
ijpds-3902	134	2	2021	CARDINAL
ijpds-3902	134	3	13(1	DATE
ijpds-3902	134	4	64	CARDINAL
ijpds-3902	135	1	10	CARDINAL
ijpds-3902	136	1	mohanan s.	GPE
ijpds-3902	137	1	asian	NORP
ijpds-3902	137	2	j pharm clin res	PERSON
ijpds-3902	137	3	2018	DATE
ijpds-3902	137	4	11(11): 43741	DATE
ijpds-3902	138	1	11	CARDINAL
ijpds-3902	141	1	ejbps	ORG
ijpds-3902	141	2	2017	DATE
ijpds-3902	141	3	4(12	CARDINAL
ijpds-3902	141	4	743-50	CARDINAL
ijpds-3902	142	1	12	CARDINAL
ijpds-3902	143	1	parthy	CARDINAL
ijpds-3902	143	2	m. malyadri	PERSON
ijpds-3902	143	3	saibabu c. formulation development	ORG
ijpds-3902	144	1	2021	CARDINAL
ijpds-3902	144	2	6(3):69	CARDINAL
ijpds-3902	144	3	13	CARDINAL
ijpds-3902	145	1	jain s	PERSON
ijpds-3902	145	2	malviya n. physicochemical	PERSON
ijpds-3902	145	3	2012	DATE
ijpds-3902	145	4	3(3	CARDINAL
ijpds-3902	145	5	909-13	DATE
ijpds-3902	146	1	viresh k chandur	PERSON
ijpds-3902	146	2	ramkrishna shabaraya a. characterization	PERSON
ijpds-3902	147	1	indian	NORP
ijpds-3902	148	1	2023	CARDINAL
ijpds-3902	148	2	2(2	CARDINAL
ijpds-3902	148	3	82-86	DATE